Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Clinical Lymphoma, Myeloma & Leukemia
|
January 10, 2021
Direct Medical Costs Associated With Treatment Nonpersistence in Patients With Higher-Risk Myelodysplastic Syndromes Receiving Hypomethylating Agents: A Large Retrospective Cohort Analysis
Namita Joshi, Hrishikesh Kale, Shelby Corman, et al.
Surgical Neurology International
|
January 26, 2022
Extremely rare case of retropharyngeal space benign plexiform schwannoma - Excised through Smith- Robinson Approach
Rajendra Sakhrekar, Vishal Peshattiwar, Ravikant Jadhav, et al.
Journal of Affective Disorders
|
August 28, 2025
Economic, clinical, and humanistic burden associated with major depressive disorder with prominent anhedonia in the United States: analysis of medical expenditure panel survey
Hrishikesh Kale, Michael L Ganz, Rajrupa Ghosh, et al.
The International Journal of Neuropsychopharmacology
|
July 2, 2025
Association between anhedonia severity and clinical, humanistic, and economic outcomes among US adults with major depressive disorder
Hrishikesh Kale, M Janelle Cambron-Mellott, Tiina Drissen, et al.
Pharmacoepidemiology and Drug Safety
|
June 12, 2014
Reductions in reported deaths following the introduction of extended-release oxycodone (OxyContin) with an abuse-deterrent formulation
Nelson E Sessler, Jerod M Downing, Hrishikesh Kale, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 25, 2022
Impact of Hypomethylating Agent Use on Hospital and Emergency Room Visits, and Predictors of Early Discontinuation in Patients With Higher-Risk Myelodysplastic Syndromes
Amer M Zeidan, Namita Joshi, Hrishikesh Kale, et al.
Advances in Therapy
|
March 17, 2022
Impact of Infliximab-dyyb (Infliximab Biosimilar) on Clinical and Patient-Reported Outcomes: 1-Year Follow-up Results from an Observational Real-World Study Among Patients with Inflammatory Bowel Disease in the US and Canada (the ONWARD Study)
Bincy Abraham, Bertus Eksteen, Khan Nedd, et al.
BMC Psychiatry
|
July 27, 2025
Clinical burden of major depressive disorder with versus without prominent anhedonia using a real-world electronic health records and claims linked database
Hrishikesh Kale, Stevan Geoffrey Severtson, Becca S Feldman, et al.
Journal of Affective Disorders
|
December 18, 2024
Economic and clinical burden of major depressive disorder with insomnia symptoms in commercially and Medicaid-insured adults in the United States: A retrospective matched cohort study
Hrishikesh Kale, Maryia Zhdanava, Dominic Pilon, et al.
Current Problems in Diagnostic Radiology
|
July 4, 2017
Radiology Online Patient Education Materials Provided by Major University Hospitals: Do They Conform to NIH and AMA Guidelines?
Arpan V Prabhu, Ashley L Donovan, Tudor Crihalmeanu, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Clinical Lymphoma, Myeloma & Leukemia
|
January 10, 2021
Direct Medical Costs Associated With Treatment Nonpersistence in Patients With Higher-Risk Myelodysplastic Syndromes Receiving Hypomethylating Agents: A Large Retrospective Cohort Analysis
Namita Joshi, Hrishikesh Kale, Shelby Corman, et al.
Surgical Neurology International
|
January 26, 2022
Extremely rare case of retropharyngeal space benign plexiform schwannoma - Excised through Smith- Robinson Approach
Rajendra Sakhrekar, Vishal Peshattiwar, Ravikant Jadhav, et al.
Journal of Affective Disorders
|
August 28, 2025
Economic, clinical, and humanistic burden associated with major depressive disorder with prominent anhedonia in the United States: analysis of medical expenditure panel survey
Hrishikesh Kale, Michael L Ganz, Rajrupa Ghosh, et al.
The International Journal of Neuropsychopharmacology
|
July 2, 2025
Association between anhedonia severity and clinical, humanistic, and economic outcomes among US adults with major depressive disorder
Hrishikesh Kale, M Janelle Cambron-Mellott, Tiina Drissen, et al.
Pharmacoepidemiology and Drug Safety
|
June 12, 2014
Reductions in reported deaths following the introduction of extended-release oxycodone (OxyContin) with an abuse-deterrent formulation
Nelson E Sessler, Jerod M Downing, Hrishikesh Kale, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 25, 2022
Impact of Hypomethylating Agent Use on Hospital and Emergency Room Visits, and Predictors of Early Discontinuation in Patients With Higher-Risk Myelodysplastic Syndromes
Amer M Zeidan, Namita Joshi, Hrishikesh Kale, et al.
Advances in Therapy
|
March 17, 2022
Impact of Infliximab-dyyb (Infliximab Biosimilar) on Clinical and Patient-Reported Outcomes: 1-Year Follow-up Results from an Observational Real-World Study Among Patients with Inflammatory Bowel Disease in the US and Canada (the ONWARD Study)
Bincy Abraham, Bertus Eksteen, Khan Nedd, et al.
BMC Psychiatry
|
July 27, 2025
Clinical burden of major depressive disorder with versus without prominent anhedonia using a real-world electronic health records and claims linked database
Hrishikesh Kale, Stevan Geoffrey Severtson, Becca S Feldman, et al.
Journal of Affective Disorders
|
December 18, 2024
Economic and clinical burden of major depressive disorder with insomnia symptoms in commercially and Medicaid-insured adults in the United States: A retrospective matched cohort study
Hrishikesh Kale, Maryia Zhdanava, Dominic Pilon, et al.
Current Problems in Diagnostic Radiology
|
July 4, 2017
Radiology Online Patient Education Materials Provided by Major University Hospitals: Do They Conform to NIH and AMA Guidelines?
Arpan V Prabhu, Ashley L Donovan, Tudor Crihalmeanu, et al.
Page
of 2